Dr. Nazha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
R35
Cleveland, OH 44106Phone+1 215-444-2526
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2013 - 2016
- University of Texas M.D. Anderson Cancer CenterFellowship, Leukemia Fellowship, 2011 - 2012
- AtlantiCare Regional Medical CenterResidency, Internal Medicine, 2008 - 2011
- University of Tichreen Faculty of MedicineClass of 2007
Certifications & Licensure
- NJ State Medical License 2021 - 2025
- OH State Medical License 2013 - 2022
- TX State Medical License 2011 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Paul Calabresi Career Development Award (NIH K12) NIH, Case Comprehensive Cancer Center, 2016
- AACR/ASCO Methods in Clinical Cancer Research Scholarship AACR/ASCO, 2016
- Peskind Memorial Award for Excellence in Scientific Research Cleveland Clinic, 2016
- Join now to see all
Clinical Trials
- TET2 Mutations in Myelodysplastic Syndromes and Acute Myeloid Leukemia With Azacitidine + Ascorbic Acid Start of enrollment: 2018 Mar 16
- Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias Start of enrollment: 2018 Oct 29
- Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia Start of enrollment: 2019 Jun 06
- Join now to see all
Publications & Presentations
PubMed
- 120 citationsIncorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.Aziz Nazha, Mayur Narkhede, Tomas Radivoyevitch, David J. Seastone, Bhumika J. Patel
Leukemia. 2016-06-17 - 24 citationsMolecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.Aziz Nazha, Rafael Bejar
Current Hematologic Malignancy Reports. 2017-08-26 - 13 citationsThe MDS genomics-prognosis symbiosisAziz Nazha
Hematology. American Society of Hematology. Education Program. 2018-11-30
Journal Articles
- Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
- An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategiesPadron E, Garcia-Manero G, Patnaik MM, Itzykson R, Lasho T, Nazha A, Rampal RK, Sanchez ME, Jabbour E, Al Ali NH, Thompson Z, Colla S, Fenaux P, Kantarjian HM, Killick..., Blood Cancer J, 1/31/2015
- Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical and Therapeutic ImplicationsNazha A, Khoury JD, Rampal R, Daver N, Oncologist, 1/24/2015
- Join now to see all
Abstracts/Posters
- Epigenomic Signatures in Myelodysplastic Syndrome Patients As Predictors of Donor Compatibility and Transplant OutcomeAziz Nazha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid NeoplasmsAziz Nazha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Preliminary Results from the Phase II Study of the IDH2-Inhibitor Enasidenib in Patients with High-Risk IDH2-Mutated Myelodysplastic Syndromes (MDS)Aziz Nazha, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- The Molecular Maelstrom of Myelodysplastic Syndromes (MDS)60th American Society of Hematology Annual Meeting - 12/2/2018
- Genomic Biomarkers Predict Response/Resistance to Lenalidomide in Non-Del(5q) Myelodysplastic Syndromes2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- ASH 2020 Study Preview: CBC Values as a Predicting Factor of Hypomethylating AgentsDecember 2020
Press Mentions
- New Prognostic Model Outperforms Established Predictive Models in MDSOctober 18th, 2021
- A Personalised Prediction Model Based on Clinical and Genomic Data Outperforms Established Prognostic Models in MDSSeptember 2nd, 2021
- Virtual Workshop: Transforming the Practice of Mental Health CareApril 24th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Arabic
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: